A detailed history of Banco Santander, S.A. transactions in Dexcom Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 9,900 shares of DXCM stock, worth $770,220. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,900
Previous 9,990 0.9%
Holding current value
$770,220
Previous $1.13 Million 41.43%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $5,760 - $10,445
-90 Reduced 0.9%
9,900 $663,000
Q2 2024

Jul 29, 2024

SELL
$110.31 - $140.45 $14,340 - $18,258
-130 Reduced 1.28%
9,990 $1.13 Million
Q1 2024

May 10, 2024

SELL
$114.22 - $140.1 $12,564 - $15,411
-110 Reduced 1.08%
10,120 $1.4 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $4.21 Million - $6.93 Million
-55,819 Reduced 84.51%
10,230 $1.27 Million
Q3 2023

Nov 08, 2023

BUY
$86.06 - $137.93 $605,518 - $970,475
7,036 Added 11.92%
66,049 $6.16 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $6.04 Million - $7.03 Million
53,703 Added 1011.36%
59,013 $7.58 Million
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $230,984 - $273,005
2,221 Added 71.9%
5,310 $616,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $262,503 - $378,927
3,089 New
3,089 $349,000
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $636,263 - $880,542
-6,763 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $878,310 - $1.1 Million
6,763 New
6,763 $3.63 Million
Q1 2021

May 10, 2021

SELL
$84.79 - $104.74 $767,010 - $947,478
-9,046 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $386,412 - $517,693
4,954 Added 121.07%
9,046 $3.34 Million
Q3 2020

Nov 09, 2020

BUY
$95.51 - $112.95 $114,707 - $135,652
1,201 Added 41.54%
4,092 $1.69 Million
Q2 2020

Aug 05, 2020

BUY
$62.68 - $105.34 $181,207 - $304,537
2,891 New
2,891 $1.17 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.